U.S. market Closed. Opens in 1 hour 1 minute

NVO | Novo Nordisk A/S Stock Fundamentals

(Stock Exchange: NYSE)
Analyzing fundamentals for NVO we got that it has strong fundamentals where Valuation is considered to be fairly valued, Profitability is stunning wealthy, Growth is very good and Health is passable.

Valuation (57%)

Company Industry
P/E Ratio (TTM) 38.28 -23.05
PEG Ratio (TTM) 44.96 15.47
P/S Ratio (TTM) 13.36 49.46
P/B Ratio (TTM) 30.58 18.87
P/FCF Ratio (TTM) 52.22 -3.27
Price to 5YR AVG Earnings Ratio 9.56 -3.55
Price to 5YR AVG FCF Ratio 10.12 -9.37

Profitability (100%)

Company Industry
ROA (TTM) 24.34% -5.14%
ROE (TTM) 87.50% 16.69%
Net Profit Margin (TTM) 34.84% -1,583.93%
ROIC 5YR AVG 83.57% 15.15%

Growth (72%)

4QTR AVG 3YR AVG 5YR AVG
EPS 2.19% -7.78% 9.37%
Revenue 5.92% 8.02% 16.20%
Net Income 2.00% 7.45% 17.87%
Cash Flow 67.34% 7.26% 20.65%

Health (60%)

Company Industry
Current Ratio (TTM) 0.94 6.13
Quick Ratio (TTM) 0.75 5.85
D/E Ratio (TTM) 0.51 -15.81
Interest Coverage (TTM) 30.14 -1.57
Piotroski F-Score 8 5
Altman Z-Score 3.30 14.12
LTL to 5YR AVG FCF 0.42 0.17
Shares Outstanding Growth 5YR AVG 18.11% 123.44%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙